Virtu Financial LLC Ionis Pharmaceuticals Inc Transaction History

Virtu Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$31.71 - $43.0 $722,797 - $980,142	22,794 New	22,794 $844,000
Q2 2021 Sep 17, 2021	SELL	$34.54 - $47.25 $495,994 - $678,510	-14,360 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$42.51 - $63.78 $610,443 - $915,880	14,360 New	14,360 $646,000
Q4 2020 Feb 24, 2021	SELL	$45.3 - $60.27 $806,113 - $1.07 Million	-17,795 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$47.45 - $62.95 $557,584 - $739,725	11,751 Added 194.42%	17,795 $844,000
Q2 2020 Aug 07, 2020	BUY	$46.85 - $61.05 $283,161 - $368,986	6,044 New	6,044 $356,000
Q3 2019 Nov 20, 2019	SELL	$59.06 - $72.15 $321,227 - $392,423	-5,439 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $223,648 - $310,276	-3,602 Reduced 39.84%	5,439 $350,000
Q1 2019 Apr 12, 2019	SELL	$52.92 - $81.17 $322,335 - $494,406	-6,091 Reduced 40.25%	9,041 $734,000
Q1 2018 May 14, 2018	BUY	$44.08 - $55.05 $337,476 - $421,462	7,656 Added 102.41%	15,132 $667,000
Q4 2017 Feb 09, 2018	SELL	$50.3 - $64.39 $870,843 - $1.11 Million	-17,313 Reduced 69.84%	7,476 $376,000
Q3 2017 Nov 15, 2017	BUY	$45.56 - $59.57 $1.13 Million - $1.48 Million	24,789	24,789 $1,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.